Hennion & Walsh Asset Management’s Bio-Techne TECH Stock Holding History

Hennion & Walsh Asset Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,926	Closed	-$1.14M	–	838
2023 Q2	$1.14M	Sell	13,926 -1,438	-9%	-$116K	0.07%	356
2023 Q1	$1.14M	Sell	15,364 -13,849	-47%	-$1.07M	0.07%	334
2022 Q4	$2.42M	Sell	29,213 -2,035	-7%	-$162K	0.15%	174
2022 Q3	$2.22M	Sell	31,248 -16,836	-35%	-$1.45M	0.15%	181
2022 Q2	$4.17M	Sell	48,084 -1,672	-3%	-$157K	0.26%	98
2022 Q1	$5.39M	Sell	49,756 -15,024	-23%	-$1.55M	0.29%	90
2021 Q4	$8.38M	Buy	64,780 +5,276	+9%	+$647K	0.41%	57
2021 Q3	$7.21M	Buy	59,504 +176	+0.3%	+$21.4K	0.38%	58
2021 Q2	$6.68M	Buy	59,328 +2,620	+5%	+$276K	0.36%	64
2021 Q1	$5.42M	Buy	+56,708	New	+$5.17M	0.33%	76

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hennion & Walsh Asset Management's TECH Position: Q3 2023 in Review

Hennion & Walsh Asset Management sold out of Bio-Techne (TECH) in Q3 2023, closing a stake of 13,926 shares — an estimated $1.14M sold.

Hennion & Walsh Asset Management first reported a position in TECH in Q1 2021 and held it in 10 quarters. The position peaked at $8.38M in Q4 2021. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

Hennion & Walsh Asset Management reported no remaining Bio-Techne position as of Q3 2023 after selling out during the quarter.
Hennion & Walsh Asset Management sold 13,926 Bio-Techne shares in Q3 2023, an estimated $1.14M.
Hennion & Walsh Asset Management first reported a position in Bio-Techne in Q1 2021 and held it in 10 quarters.
Hennion & Walsh Asset Management's Bio-Techne position peaked at $8.38M in Q4 2021.
530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2023, filed 27 Oct 2023.